FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christopher Chapple

Research Profile

Anatomy

Disorders

Physiology

Urodynamics

Chemicals & Drugs

Concepts & Ideas

Phenomena

Muscle Contraction

Procedures

Double-Blind Method

Co-author Network

Publications

TOP 3
Nadir I Osman; S Roman; A Mangera; A J Bullock; Christopher Chapple; G Gigliobianco; Sheila MacNeil
Tissue engineering as a potential alternative or adjunct to surgical reconstruction in treating pelvic organ prolapse: comment on Boennelycke et al.
Donna Daly; Christopher Chapple
Relationship between overactive bladder (OAB) and irritable bowel syndrome (IBS): concurrent disorders with a common pathophysiology?
Christopher Chapple; Nadir Osman; Sheila MacNeil
Developing tissue-engineered solutions for the treatment of extensive urethral strictures.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christopher Chapple (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nadir I Osman; S Roman; A Mangera; A J Bullock; Christopher Chapple; G Gigliobianco; Sheila MacNeil
Tissue engineering as a potential alternative or adjunct to surgical reconstruction in treating pelvic organ prolapse: comment on Boennelycke et al.
International urogynecology journal 2013;24(5):881.
2013: Donna Daly; Christopher Chapple
Relationship between overactive bladder (OAB) and irritable bowel syndrome (IBS): concurrent disorders with a common pathophysiology?
BJU international 2013;111(4):530-1.
2013: Christopher Chapple; Nadir Osman; Sheila MacNeil
Developing tissue-engineered solutions for the treatment of extensive urethral strictures.
European urology 2013;63(3):539-41.
2013: Christopher Chapple
Urinary incontinence - a challenge to the physiologist Joint symposium for the EU/FP7 networks INComb and TRUST in collaboration with the Swedish Enuresis Academy (SEA), Stockholm 2011.
Acta physiologica (Oxford, England) 2013;207(1):5-6.
2013: Nadir I Osman; Christopher Chapple; A J Wein
Nocturia: current concepts and future perspectives.
Acta physiologica (Oxford, England) 2013;207(1):53-65.
2012: N I Osman; Christopher Chapple
Lower urinary tract symptoms revisited.
International journal of clinical practice 2012;66(6):527-9.
2012: Christopher Chapple; S Macneil
Tissue engineered oral mucosa for urethroplasty: past experience and future directions.
The Journal of urology 2012;187(5):1533-4.
2012: Karin S Coyne; Andrea Ireland; Zoe Kopp; Ian Milsom; Christine Thompson; Alexandra I Barsdorf; Christopher Chapple; Tamara Bavendam
Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS).
Neurourology and urodynamics 2012;31(4):448-54.
2012: Karin S Coyne; Andrea M Ireland; Zoe Kopp; Marion Kvasz; Ian Milsom; Christopher Chapple
Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States.
European urology 2012;61(1):88-95.
2011: Karin S Coyne; Caty Ebel-Bitoun; Zoe Kopp; Ian Milsom; Chris C Sexton; Christopher Chapple
The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
BJU international 2011;108(9):1459-71.
2011: Christopher Chapple
Systematic review of therapy for men with overactive bladder.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2011;5(5 Suppl 2):S143-5.
2011: Christopher Chapple
Pathophysiology of the lower urinary tract and CNS.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2011;5(5 Suppl 2):S126-7.
2011: Christopher Chapple
Female urology.
Current opinion in urology 2011;21(4):267.
2011: Christopher Chapple
Intraprostatic injection therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
European urology 2011;59(5):755-6.
2010: Michael G Kirby; Adrian Wagg; Linda Cardozo; Christopher Chapple; David Castro-Diaz; Dirk De Ridder; Montserrat Espuna-Pons; François Haab; Con Kelleher; Heinz Kölbl; Ian Milsom; Philip van Kerrebroeck; Mark E Vierhout; Stefano Salvatore; Andrea Tubaro
Overactive bladder: Is there a link to the metabolic syndrome in men?
Neurourology and urodynamics 2010;29(8):1360-4.
2010: Christopher Chapple
New once-daily formulation for trospium in overactive bladder.
International journal of clinical practice 2010;64(11):1535-40.
2010: Karin S Coyne; C C Sexton; Zoe Kopp; Christopher Chapple; S A Kaplan; L P Aiyer; T Symonds
Assessing patients' descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research.
International journal of clinical practice 2010;64(9):1260-78.
2010: Donna M Daly; Russell Chess-Williams; Christopher Chapple; David Grundy
The inhibitory role of acetylcholine and muscarinic receptors in bladder afferent activity.
European urology 2010;58(1):22-8; discussion 31-2.
2010: T A de Boer; S Salvatore; L Cardozo; Christopher Chapple; C Kelleher; P van Kerrebroeck; M G Kirby; H Koelbl; M Espuna-Pons; I Milsom; A Tubaro; A Wagg; Mark E Vierhout
Pelvic organ prolapse and overactive bladder.
Neurourology and urodynamics 2010;29(1):30-9.
2010: Christopher Chapple
Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia.
Current opinion in urology 2010;20(1):43-8.
2009: Linda Cardozo; Christopher Chapple; R Dmochowski; M P Fitzgerald; P Hanno; M C Michel; david staskin; P Van Kerrebroeck; J-J Wyndaele; O Yamaguchi; M Yoshida
Urinary urgency - translating the evidence base into daily clinical practice.
International journal of clinical practice 2009;63(12):1675-82.
2009: J Alfred Witjes; Giulio Del popolo; M Marberger; O Jonsson; H P Kaps; Christopher Chapple
A multicenter, double-blind, randomized, parallel group study comparing polyvinyl chloride and polyvinyl chloride-free catheter materials.
The Journal of urology 2009;182(6):2794-8.
2009: Christopher Chapple; Dirk De Ridder
The second-line management of idiopathic overactive bladder: what is the place of sacral neuromodulation and botulinum toxin-A in contemporary practice?
BJU international 2009;104(9):1188-90.
2009: Christopher Chapple; Sender Herschorn; Paul Abrams; Franklin Sun; Marina Brodsky; Zhonghong Guan
Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
European urology 2009;56(3):534-41.
2009: Martin C Michel; Christopher Chapple
Basic mechanisms of urgency: preclinical and clinical evidence.
European urology 2009;56(2):298-307.
2009: Per-Anders Abrahamsson; Walter Artibani; Christopher Chapple; Manfred Wirth
European Association of Urology position statement on screening for prostate cancer.
European urology 2009;56(2):270-1.
2009: Karin S Coyne; Chris C Sexton; Christine L Thompson; Ian Milsom; Debra E Irwin; Zoe Kopp; Christopher Chapple; Steven Kaplan; Andrea Tubaro; Lalitha P Aiyer; Alan J Wein
The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study.
BJU international 2009;104(3):352-60.
2009: Christopher Chapple
Urinary incontinence: oxybutynin topical gel for overactive bladder.
Nature reviews. Urology 2009;6(7):351-2.
2009: Christopher Chapple
Editorial comment. Female urology.
Current opinion in urology 2009;19(4):335-6.
2009: Karl-Erik Andersson; Christopher Chapple; Linda Cardozo; Francisco Cruz; Hashim Hashim; Martin C Michel; Cara Tannenbaum; Alan J Wein
Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence.
Current opinion in urology 2009;19(4):380-94.
2009: Christopher Chapple
Lower urinary tract symptoms revisited.
European urology 2009;56(1):21-3.
2009: Susan A Hall; Carol L Link; Sharon L Tennstedt; Patrick Mollon; Lalitha Padmanabhan Aiyer; Christopher Chapple; Alan J Wein; Raymond C Rosen
Urological symptom clusters and health-related quality-of-life: results from the Boston Area Community Health Survey.
BJU international 2009;103(11):1502-8.
2009: Steven A Kaplan; Claus G Roehrborn; Christopher Chapple; Raymond C Rosen; Debra E Irwin; Zoe Kopp; Lalitha P Aiyer; Patrick Mollon
Implications of recent epidemiology studies for the clinical management of lower urinary tract symptoms.
BJU international 2009;103 Suppl 3():48-57.
2009: Karin S Coyne; Steven A Kaplan; Christopher Chapple; Chris C Sexton; Zoe S Kopp; Elizabeth N Bush; Lalitha P Aiyer
Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS.
BJU international 2009;103 Suppl 3():24-32.
2009: Chris C Sexton; Karin S Coyne; Zoe S Kopp; Debra E Irwin; Ian Milsom; Lalitha P Aiyer; Andrea Tubaro; Christopher Chapple; Alan J Wein
The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS.
BJU international 2009;103 Suppl 3():12-23.
2009: Christopher Chapple; Steven A Kaplan
Lower urinary tract symptoms: new perspectives on prevalence, burden and comorbidities. Introduction.
BJU international 2009;103 Suppl 3():1-3.
2009: Paul Abrams; Christopher Chapple; S Khoury; C Roehrborn; J de la Rosette
Evaluation and treatment of lower urinary tract symptoms in older men.
The Journal of urology 2009;181(4):1779-87.
2009: Steven Morant; Glenys Bloomfield; Vasudha Vats; Christopher Chapple
Increased sexual dysfunction in men with storage and voiding lower urinary tract symptoms.
The journal of sexual medicine 2009;6(4):1103-10.
2009: Christopher Chapple
Words of wisdom. Re: Lingual mucosal graft urethroplasty for anterior urethral reconstruction.
European urology 2009;55(3):752-3.
2009: Christopher Chapple
Words of wisdom. Re: Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
European urology 2009;55(3):748.
2009: Christopher Chapple
Editorial.
Neurourology and urodynamics 2009;28(5):367.
2009: Christopher Chapple
Old words revisited--the importance of standardisation.
Neurourology and urodynamics 2009;28(4):267.
2009: Hashim Hashim; Christopher Chapple
What's hot from the ICS annual meeting 2008.
Neurourology and urodynamics 2009;28(1):2-7.
2009: Christopher Chapple
Editorial comment on: Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report.
European urology 2009;55(1):120.
2008: Anand K Patel; Christopher Chapple
Lower urinary tract symptoms and urinary incontinence.
The Ceylon medical journal 2008;53(4):117-20.
2008: Hironobu Akino; Christopher Chapple; Neil McKay; Rebecca L Cross; Shigetaka Murakami; Osamu Yokoyama; Russell Chess-Williams; Donna J Sellers
Spontaneous contractions of the pig urinary bladder: the effect of ATP-sensitive potassium channels and the role of the mucosa.
BJU international 2008;102(9):1168-74.
2008: Christopher Chapple; Philip van Kerrebroeck; Klaus-Peter Jünemann; Joseph T Wang; Marina Brodsky
Comparison of fesoterodine and tolterodine in patients with overactive bladder.
BJU international 2008;102(9):1128-32.
2008: Adrian Wagg; Linda Cardozo; Christopher Chapple; D C Diaz; Dirk De Ridder; M Espuna-Pons; F Haab; Con Kelleher; H Kolbl; Ian Milsom; P Van Kerrebroeck; Mark E Vierhout; Michael Kirby
Overactive Bladder and Continence Guidelines: implementation, inaction or frustration?
International journal of clinical practice 2008;62(10):1588-93.
2008: S Colman; Christopher Chapple; V Nitti; C Haag-Molkenteller; C Hastedt; U Massow
Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder.
Urology 2008;72(4):803-7.
2008: Ramandeep K Basra; Adrian Wagg; Christopher Chapple; Linda Cardozo; David Castro-Diaz; Montserrat Espuna Pons; Michael Kirby; Ian Milsom; Mark E Vierhout; Philip van Kerrebroeck; Con Kelleher
A review of adherence to drug therapy in patients with overactive bladder.
BJU international 2008;102(7):774-9.
2008: Christopher Chapple; Vik Khullar; Zahava Gabriel; Dominic Muston; Caty Ebel Bitoun; David Weinstein
The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis.
European urology 2008;54(3):543-62.
2008: Christopher Chapple; Alan J Wein; Paul Abrams; Roger R Dmochowski; François Giuliano; Steven A Kaplan; Kevin T McVary; Claus G Roehrborn
Lower urinary tract symptoms revisited: a broader clinical perspective.
European urology 2008;54(3):563-9.
2008: Christopher Chapple
Editorial comment on: the use of lingual mucosal graft in adult anterior urethroplasty: surgical steps and short-term outcome.
European urology 2008;54(3):676.
2008: Christopher Chapple; Saurabh Bhargava
Management of the failure of a permanently implanted urethral stent-a therapeutic challenge.
European urology 2008;54(3):665-70.
2008: Lambertus Witte; Christopher Chapple; Jean J M C H de la Rosette; Martin C Michel
Cholinergic innervation and muscarinic receptors in the human prostate.
European urology 2008;54(2):326-34.
2008: Anand K Patel; Christopher Chapple
Urodynamics in the management of female stress incontinence--which test and when?
Current opinion in urology 2008;18(4):359-64.
2008: Christopher Chapple; Francisco Cruz
Open to debate. The Motion: antimuscarinics are the mainstay of therapy for overactive bladder.
European urology 2008;54(1):226-30.
2008: Jacob M Patterson; Christopher Chapple
Surgical techniques in substitution urethroplasty using buccal mucosa for the treatment of anterior urethral strictures.
European urology 2008;53(6):1162-71.
2008: Saurabh Bhargava; Jacob M Patterson; Richard D Inman; Sheila MacNeil; Christopher Chapple
Tissue-engineered buccal mucosa urethroplasty-clinical outcomes.
European urology 2008;53(6):1263-9.
2008: S V Morant; K Reilly; G A Bloomfield; Christopher Chapple
Diagnosis and treatment of lower urinary tract symptoms suggestive of overactive bladder and bladder outlet obstruction among men in general practice in the UK.
International journal of clinical practice 2008;62(5):688-94.
2008: Paula Nicolson; Zoe Kopp; Christopher Chapple; C Kelleher
It's just the worry about not being able to control it! A qualitative study of living with overactive bladder.
British journal of health psychology 2008;13(Pt 2):343-59.
2008: Anand K Patel; Christopher Chapple
Medical management of lower urinary tract symptoms in men: current treatment and future approaches.
Nature clinical practice. Urology 2008;5(4):211-9.
2008: Christopher Chapple
EIC editorial-27:4.
Neurourology and urodynamics 2008;27(4):263.
2008: Derek J Rosario; Henry H Woo; Christopher Chapple
Definition of normality of pressure-flow parameters based on observations in asymptomatic men.
Neurourology and urodynamics 2008;27(5):388-94.
2007: Vivek Kumar; Christopher Chapple; Ann Marie Surprenant; Russell Chess-Williams
Enhanced adenosine triphosphate release from the urothelium of patients with painful bladder syndrome: a possible pathophysiological explanation.
The Journal of urology 2007;178(4 Pt 1):1533-6.
2007: Christopher Chapple; C DuBeau; U Ebinger; Ludmyla Rekeda; A Viegas
Darifenacin treatment of patients >or= 65 years with overactive bladder: results of a randomized, controlled, 12-week trial.
Current medical research and opinion 2007;23(10):2347-58.
2007: Christopher Chapple; Philip van Kerrebroeck; Andrea Tubaro; Cornelia Haag-Molkenteller; Hans-Theo Forst; Ute Massow; Joseph Wang; Marina Brodsky
Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder.
European urology 2007;52(4):1204-12.
2007: Christopher Chapple; Aino Fianu-Jonsson; Mark Indig; Vik Khullar; José Rosa; Roberto M Scarpa; Arun Mistry; D Mark Wright; John Bolodeoku
Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg.
European urology 2007;52(4):1195-203.
2007: Christopher Chapple; Anand K Patel
A pragmatic approach to the primary care management of men with lower urinary tract symptoms.
International journal of clinical practice 2007;61(9):1423-5.
2007: Donna Daly; Weifang Rong; R Chess-Williams; Christopher Chapple; David Grundy
Bladder afferent sensitivity in wild-type and TRPV1 knockout mice.
The Journal of physiology 2007;583(Pt 2):663-74.
2007: Christopher Chapple; Anand K Patel
How robust is the evidence for slings in the treatment of stress urinary incontinence?
European urology 2007;52(3):645-7.
2007: Laurie A Stevens; Christopher Chapple; Russell Chess-Williams
Human idiopathic and neurogenic overactive bladders and the role of M2 muscarinic receptors in contraction.
European urology 2007;52(2):531-8.
2007: Malcolm Lucas; Simon Harrison; Christopher Chapple
Specialist training in female urology and reconstructive urology: the UK experience.
Current opinion in urology 2007;17(4):248-51.
2007: Christopher Chapple
Response to P. Hilton: of porcupines and poodles-a joint challenge to industry and the profession.
International urogynecology journal and pelvic floor dysfunction 2007;18(7):835; author reply 837.
2007: Ramandeep Basra; Walter Artibani; Linda Cardozo; David Castro-Diaz; Christopher Chapple; Eduardo Cortes; Dirk De Ridder; Montserrat Espuna Pons; François Haab; Markus Hohenfellner; Michael Kirby; Ian Milsom; Philip van Kerrebroeck; Mark E Vierhout; Adrian Wagg; Con Kelleher
Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ).
European urology 2007;52(1):230-7.
2007: Christopher Chapple
[Comment on the STAR study: Comparison of the efficacy and tolerance of solifenacin and tolterodine retard in the treatment of overactive bladder].
Der Urologe. Ausg. A 2007;46(4):422, 424-6; author reply 426, 428.
2007: Shigetaka Murakami; Christopher Chapple; Hironobu Akino; Donna J Sellers; Russell Chess-Williams
The role of the urothelium in mediating bladder responses to isoprenaline.
BJU international 2007;99(3):669-73.
2007: Adrian Wagg; Linda Cardozo; Christopher Chapple; Dirk De Ridder; Con Kelleher; Michael Kirby; Ian Milsom; Mark E Vierhout
Overactive bladder syndrome in older people.
BJU international 2007;99(3):502-9.
2007: Derek J Rosario; Joshua T Phillips; Christopher Chapple
Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
The Journal of urology 2007;177(3):1047-51; discussion 1051.
2007: Sylvia M Bates; Valerie A Hill; John B Anderson; Christopher Chapple; Rosemary Spence; Claire Ryan; Martin D Talbot
A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.
BJU international 2007;99(2):355-9.
2007: Christopher Chapple; Linda Brubaker; François Haab; Philip van Kerrebroeck; Dudley Robinson
Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy.
International urogynecology journal and pelvic floor dysfunction 2007;18(2):199-205.
2007: Christopher Chapple; Anand K Patel
Lower urinary tract symptoms in men.
BMJ (Clinical research ed.) 2007;334(7583):2.
2007: A K Patel; Christopher Chapple
What's hot from the ICS Annual Meeting 2007.
Neurourology and urodynamics 2007;26(7):956-65.
2007: Osamu Yamaguchi; Christopher Chapple
Beta3-adrenoceptors in urinary bladder.
Neurourology and urodynamics 2007;26(6):752-6.
2007: Christopher Chapple
The new publication policy of Neurourology and Urodynamics.
Neurourology and urodynamics 2007;26(2):145-6.
2007: Adrian Wagg; Amitabha Majumdar; Philip Toozs-Hobson; Anand K Patel; Christopher Chapple; Simon Hill
Current and future trends in the management of overactive bladder.
International urogynecology journal and pelvic floor dysfunction 2007;18(1):81-94.
2006: Anand K Patel; Jacob M Patterson; Christopher Chapple
The emerging role of intravesical botulinum toxin therapy in idiopathic detrusor overactivity.
International journal of clinical practice. Supplement 2006;(151):27-32.
2006: A K Patel; Christopher Chapple
Botulinum toxin injection therapy in the management of lower urinary tract dysfunction.
International journal of clinical practice. Supplement 2006;(151):1-7.
2006: Christopher Chapple
Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder.
Expert opinion on pharmacotherapy 2006;7(17):2421-34.
2006: Michael Kirby; Walter Artibani; Linda Cardozo; Christopher Chapple; D C Diaz; Dirk De Ridder; M Espuna-Pons; François Haab; Con Kelleher; Ian Milsom; Philip van Kerrebroeck; Mark E Vierhout; Adrian Wagg
Overactive bladder: The importance of new guidance.
International journal of clinical practice 2006;60(10):1263-71.
2006: Anand K Patel; Jacob M Patterson; Christopher Chapple
Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: A critical analysis of results.
European urology 2006;50(4):684-709; discussion 709-10.
2006: Christopher Chapple
Alpha antagonists-from initial concept to routine clinical practice.
European urology 2006;50(4):635-42.
2006: Anand K Patel; Christopher Chapple
Benign prostatic hyperplasia: treatment in primary care.
BMJ (Clinical research ed.) 2006;333(7567):535-9.
2006: Christopher Chapple; E Ann Gormley
Developments in pharmacological therapy for the overactive bladder.
BJU international 2006;98 Suppl 1():78-87; discussion 88-9.
2006: Annie Hutchison; Richard Farmer; Christopher Chapple; Richard Berges; Ludger Pientka; Pierre Teillac; Andrzej Borkowski; Piotr Dobronski
Characteristics of patients presenting with LUTS/BPH in six European countries.
European urology 2006;50(3):555-61; discussion 562.
2006: Vik Khullar; Christopher Chapple; Zahava Gabriel; Julie Ann Dooley
The effects of antimuscarinics on health-related quality of life in overactive bladder: a systematic review and meta-analysis.
Urology 2006;68(2 Suppl):38-48.
2006: Linda Brubaker; Christopher Chapple; Karin S Coyne; Zoe Kopp
Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment.
Urology 2006;68(2 Suppl):3-8.
2006: Christopher Chapple; Linda Cardozo; W D Steers; F E Govier
Solifenacin significantly improves all symptoms of overactive bladder syndrome.
International journal of clinical practice 2006;60(8):959-66.
2006: Anand Patel; Christopher Chapple
Acute urinary retention: who is at risk and how best to manage it?
Current urology reports 2006;7(4):252-9.
2006: L A Stevens; Donna J Sellers; Neil McKay; Christopher Chapple; Russell Chess-Williams
Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder.
Autonomic & autacoid pharmacology 2006;26(3):303-9.
2006: Jacob M Patterson; Christopher Chapple
Botulinum toxin in urinary incontinence.
Current opinion in urology 2006;16(4):255-60.
2006: Anand K Patel; Christopher Chapple
Female urethral diverticula.
Current opinion in urology 2006;16(4):248-54.
2006: Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Allison Fryer; Gary Kay; Alan M Laties; Neil M Nathanson; Pankaj J Pasricha; Alan J Wein
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.
British journal of pharmacology 2006;148(5):565-78.
2006: Paul Abrams; Linda Cardozo; Christopher Chapple; Dzelal Serdarevic; Katherine Hargreaves; Vikram Khullar
Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
International journal of urology : official journal of the Japanese Urological Association 2006;13(6):692-8.
2006: Christopher Chapple
Duloxetine for male stress incontinence.
European urology 2006;49(6):958-60.
2006: Christopher Chapple
Interview with Chris Chapple. Overactive bladder: tackling the problem.
European urology 2006;49(5):921-3.
2006: Christopher Chapple; Albena Patroneva; Shane R Raines
Effect of an ATP-sensitive potassium channel opener in subjects with overactive bladder: a randomized, double-blind, placebo-controlled study (ZD0947IL/0004).
European urology 2006;49(5):879-86.
2006: Christopher Chapple
Editorial comment.
European urology 2006;49(4):725-6.
2006: Christopher Chapple; Claus G Roehrborn
A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder.
European urology 2006;49(4):651-8.
2006: Christopher Chapple; Anand Patel
Botulinum toxin--new mechanisms, new therapeutic directions?
European urology 2006;49(4):606-8.
2006: Martin C Michel; Christopher Chapple
Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL).
European urology 2006;49(3):501-8; discussion 508-9.
2006: Donna J Sellers; Christopher Chapple; Douglas P W Hay; Russell Chess-Williams
Depressed contractile responses to neurokinin A in idiopathic but not neurogenic overactive human detrusor muscle.
European urology 2006;49(3):510-8.
2006: N J A van Exel; Marc A Koopmanschap; Joseph McDonnell; Christopher Chapple; Richard Berges; Frans F H Rutten
Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six european countries: report of the TRIUMPH study.
European urology 2006;49(1):92-102.
2005: Christopher Chapple
Primer: questionnaires versus urodynamics in the evaluation of lower urinary tract dysfunction-one, both or none?
Nature clinical practice. Urology 2005;2(11):555-64.
2005: Christopher Chapple; Alan J Wein; Linda Brubaker; Roger Dmochowski; Montserrat Espuna Pons; François Haab; Simon Hill
Stress incontinence injection therapy: what is best for our patients?
European urology 2005;48(4):552-65.
2005: Christopher Chapple; R Martinez-Garcia; L Selvaggi; P Toozs-Hobson; W Warnack; T Drogendijk; D M Wright; John Bolodeoku
A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial.
European urology 2005;48(3):464-70.
2005: Christopher Chapple; François Haab; Mauro Cervigni; Christian Dannecker; Aino Fianu-Jonasson; Abdul H Sultan
An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence.
European urology 2005;48(3):488-94.
2005: Adrian Wagg; K-E Andersson; Linda Cardozo; Christopher Chapple; Michael Kirby; Con Kelleher; G Lose; Ian Milsom
Nocturia: morbidity and management in adults.
International journal of clinical practice 2005;59(8):938-45.
2005: Christopher Chapple
Contemporary therapy for overactive bladder.
International journal of clinical practice 2005;59(8):872-3.
2005: Christopher Chapple; Paul Abrams
Comparison of darifenacin and oxybutynin in patients with overactive bladder: assessment of ambulatory urodynamics and impact on salivary flow.
European urology 2005;48(1):102-9.
2005: Vivek Kumar; Rebecca L Cross; Russell Chess-Williams; Christopher Chapple
Recent advances in basic science for overactive bladder.
Current opinion in urology 2005;15(4):222-6.
2005: Richard Turner Warwick; Christopher Chapple
Urinary diversion: a new look at the terminology?
Current opinion in urology 2005;15(4):213-4.
2005: Christopher Chapple; Vik Khullar; Zahava Gabriel; Julie Ann Dooley
The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis.
European urology 2005;48(1):5-26.
2005: Christopher Chapple; William Steers; Peggy Norton; Richard Millard; Georg Kralidis; Karin Glavind; Paul Abrams
A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder.
BJU international 2005;95(7):993-1001.
2005: Helen D Bradshaw; Stephen Radley; Derek J Rosario; Christopher Chapple
Towards a better understanding of involuntary detrusor activity.
BJU international 2005;95(6):799-803.
2005: François Haab; L Cardozo; Christopher Chapple; A M Ridder
Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome.
European urology 2005;47(3):376-84.
2005: Christopher Chapple; Walter Artibani; Linda Cardozo; David Castro-Diaz; Michael D Craggs; François Haab; Vik Khullar; Eboo Versi
The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects.
BJU international 2005;95(3):335-40.
2005: Christopher Chapple; Alan J Wein; Walter Artibani; Linda Brubaker; François Haab; John P F A Heesakkers; Deborah Lightner
A critical review of diagnostic criteria for evaluating patients with symptomatic stress urinary incontinence.
BJU international 2005;95(3):327-34.
2005: Christopher Chapple; Alan J Wein
The urgency of the problem and the problem of urgency in the overactive bladder.
BJU international 2005;95(3):274-5.
2005: Christopher Chapple
A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms.
Reviews in urology 2005;7 Suppl 4():S22-30.
2005: Christopher Chapple; Richard Turner-Warwick
Vesico-vaginal fistula.
BJU international 2005;95(1):193-214.
2005: Con J Kelleher; Linda Cardozo; Christopher Chapple; Francois Haab; Arwin M Ridder
Improved quality of life in patients with overactive bladder symptoms treated with solifenacin.
BJU international 2005;95(1):81-5.
2004: Bob Djavan; Christopher Chapple; Shirin Milani; Michael Marberger
State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Urology 2004;64(6):1081-8.
2004: Saurabh Bhargava; Christopher Chapple
Rising awareness of the complications of synthetic slings.
Current opinion in urology 2004;14(6):317-21.
2004: Christopher Chapple
Darifenacin: a novel M3 muscarinic selective receptor antagonist for the treatment of overactive bladder.
Expert opinion on investigational drugs 2004;13(11):1493-500.
2004: N P Bryan; Christopher Chapple
Frequency volume charts in the assessment and evaluation of treatment: how should we use them?
European urology 2004;46(5):636-40.
2004: Christopher Chapple
Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician.
BJU international 2004;94(5):738-44.
2004: Vivek Kumar; Christopher Chapple; Russell Chess-Williams
Characteristics of adenosine triphosphate [corrected] release from porcine and human normal bladder.
The Journal of urology 2004;172(2):744-7.
2004: Christopher Chapple; G Barbagli; G Jordan; A R Mundy; N Rodrigues-Netto; V Pansadoro; J W McAninch
Consensus statement on urethral trauma.
BJU international 2004;93(9):1195-202.
2004: Saurabh Bhargava; Christopher Chapple
Buccal mucosal urethroplasty: is it the new gold standard?
BJU international 2004;93(9):1191-3.
2004: Saurabh Bhargava; Christopher Chapple; A J Bullock; Christopher M Layton; Sheila MacNeil
Tissue-engineered buccal mucosa for substitution urethroplasty.
BJU international 2004;93(6):807-11.
2004: Christopher Chapple; Stephen Radley; S W Martin; Donna J Sellers; Russell Chess-Williams
Serotonin-induced potentiation of cholinergic responses to electrical field stimulation in normal and neurogenic overactive human detrusor muscle.
BJU international 2004;93(4):599-604.
2004: Christopher Chapple; T Rechberger; S Al-Shukri; P Meffan; K Everaert; M Huang; A Ridder
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.
BJU international 2004;93(3):303-10.
2004: Saurabh Bhargava; A Erdem Canda; Christopher Chapple
A rational approach to benign prostatic hyperplasia evaluation: recent advances.
Current opinion in urology 2004;14(1):1-6.
2004: Christopher Chapple; P Araño; J L H Ruud Bosch; Dirk De Ridder; A E J L Kramer; A M Ridder
Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study.
BJU international 2004;93(1):71-7.
2003: A M Robinson; Christopher Chapple
Pyoderma gangrenosum of the penis: an interesting penile lesion.
BJU international 2003;92 Suppl 3():e62.
2003: Tomonori Yamanishi; Christopher Chapple; Kosaku Yasuda; Ken-Ichiro Yoshida; Russell Chess-Williams
The functional role of beta-adrenoceptor subtypes in mediating relaxation of pig urethral smooth muscle.
The Journal of urology 2003;170(6 Pt 1):2508-11.
2003: Lucy Templeman; Donna J Sellers; Christopher Chapple; D J Rosario; D P W Hay; Russell Chess-Williams
Investigation of neurokinin-2 and -3 receptors in the human and pig bladder.
BJU international 2003;92(7):787-92.
2003: Christopher Chapple
Urology. Introduction.
Urology 2003;62(3 Suppl 1):1-5.
2003: Bart L H Bemelmans; Christopher Chapple
Are slings now the gold standard treatment for the management of female urinary stress incontinence and if so which technique?
Current opinion in urology 2003;13(4):301-7.
2003: Vivek Kumar; Lucy Templeman; Christopher Chapple; Russell Chess-Williams
Recent developments in the management of detrusor overactivity.
Current opinion in urology 2003;13(4):285-91.
2003: Helen D Bradshaw; A T Barker; Stephen Radley; Christopher Chapple
The acute effect of magnetic stimulation of the pelvic floor on involuntary detrusor activity during natural filling and overactive bladder symptoms.
BJU international 2003;91(9):810-3.
2003: Tomonori Yamanishi; Christopher Chapple; Kosaku Yasuda; Ken-Ichiro Yoshida; Russell Chess-Williams
Role of beta-adrenoceptor subtypes in mediating relaxation of the pig bladder trigonal muscle in vitro.
Neurourology and urodynamics 2003;22(4):338-42.
2003: Helen D Bradshaw; Stephen Radley; Derek J Rosario; Christopher Chapple
Evaluating ambulatory urodynamics: a prospective study in asymptomatic women.
BJOG : an international journal of obstetrics and gynaecology 2003;110(1):83-4; author reply 84.
2003: Christopher Chapple
Clinical study of benign prostatic disease, current concepts and future prospects: randomized controlled trials versus real life practice.
Current opinion in urology 2003;13(1):1-5.
2002: Tomonori Yamanishi; Christopher Chapple; Kosaku Yasuda; Ken-Ichiro Yoshida; Russell Chess-Williams
Identification of beta-adrenoceptor subtypes in lower urinary tract of the female pig.
The Journal of urology 2002;168(6):2706-10.
2002: Christopher Chapple; Tomonori Yamanishi; Russell Chess-Williams
Muscarinic receptor subtypes and management of the overactive bladder.
Urology 2002;60(5 Suppl 1):82-8; discussion 88-9.
2002: david staskin; Alan J Wein; Karl Erik Andersson; Stuart B Bauer; Jerry G Blaivas; Kathryn L Burgio; Linda Cardozo; Christopher Chapple; Roger R Dmochowski; Suneel Gupta; Jacek L Mostwin; Joseph G Ouslander; Jeffrey P Weiss; Laura King
Overview consensus statement.
Urology 2002;60(5 Suppl 1):1-6.
2002: Russell Chess-Williams; S Mason; Donna J Sellers; M Wyllie; Christopher Chapple
The role of alpha1D-adrenoceptors in prostatic contraction examined using protection studies.
Autonomic & autacoid pharmacology 2002;22(5-6):291-6.
2002: Murali Gopalakrishnan; Steven A Buckner; Kristi Whiteaker; Char-Chang Shieh; Eduardo J Molinari; Ivan Milicic; Anthony V Daza; Rachel Davis-Taber; Victoria E Scott; Donna J Sellers; Russell Chess-Williams; Christopher Chapple; Yi Liu; Dong Liu; Jorge D Brioni; James P Sullivan; Michael Williams; William A Carroll; Michael J Coghlan
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization.
The Journal of pharmacology and experimental therapeutics 2002;303(1):379-86.
2002: Tomonori Yamanishi; Christopher Chapple; Kosaku Yasuda; Ken-Ichiro Yoshida; Russell Chess-Williams
The role of M2 muscarinic receptor subtypes mediating contraction of the circular and longitudinal smooth muscle of the pig proximal urethra.
The Journal of urology 2002;168(1):308-14.
2002: Karl-Erik Andersson; Christopher Chapple; K Höfner
Future drugs for the treatment of benign prostatic hyperplasia.
World journal of urology 2002;19(6):436-42.
2002: Christopher Chapple; Karl-Erik Andersson
Tamsulosin: an overview.
World journal of urology 2002;19(6):397-404.
2002: Lucy Templeman; Christopher Chapple; Russell Chess-Williams
Urothelium derived inhibitory factor and cross-talk among receptors in the trigone of the bladder of the pig.
The Journal of urology 2002;167(2 Pt 1):742-5.
2002: Christopher Chapple; Lisbeth Nilvebrant
Tolterodine: selectivity for the urinary bladder over the eye (as measured by visual accommodation) in healthy volunteers.
Drugs in R&D 2002;3(2):75-81.
2002: Tomonori Yamanishi; Christopher Chapple; Kosaku Yasuda; Kenichiro Yoshida; Russell Chess-Williams
The role of beta(3)-adrenoceptors in mediating relaxation of porcine detrusor muscle.
British journal of pharmacology 2002;135(1):129-34.
2002: Tomonori Yamanishi; Christopher Chapple; Kosaku Yasuda; Russell Chess-Williams
The role of M2 muscarinic receptor subtypes in mediating contraction of the pig bladder base after cyclic adenosine monophosphate elevation and/or selective M3 inactivation.
The Journal of urology 2002;167(1):397-401.
2001: Stephen Radley; Derek J Rosario; Christopher Chapple; A G Farkas
Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity.
The Journal of urology 2001;166(6):2253-8.
2001: Karl-Erik Andersson; Christopher Chapple
Oxybutynin and the overactive bladder.
World journal of urology 2001;19(5):319-23.
2001: Donna J Sellers; Christopher Chapple; Russell Chess-Williams
Potential therapeutic targets for treatment of the overactive bladder.
World journal of urology 2001;19(5):307-11.
2001: T Yamanishi; Christopher Chapple; R Chess-Williams
Which muscarinic receptor is important in the bladder?
World journal of urology 2001;19(5):299-306.
2001: Karl-Erik Andersson; Christopher Chapple; A Wein
The basis for drug treatment of the overactive bladder.
World journal of urology 2001;19(5):294-8.
2001: Russell Chess-Williams; Christopher Chapple; Tomonori Yamanishi; Kosaku Yasuda; Donna J Sellers
The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro.
Journal of autonomic pharmacology 2001;21(5-6):243-8.
2001: A J Bretland; Sheilagh V Reid; Christopher Chapple; Colby L Eaton
Role of endogenous transforming growth factor beta (TGFbeta)1 in prostatic stromal cells.
The Prostate 2001;48(4):297-304.
2001: Stephen Radley; Christopher Chapple; I C Mitsogiannis; K S Glass
Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency.
European urology 2001;39(4):383-9.
2001: Christopher Chapple
Lower urinary tract symptoms suggestive of benign prostatic obstruction--Triumph: design and implementation.
European urology 2001;39 Suppl 3():31-6.
2001: Christopher Chapple
Introduction and conclusions. Improving the management of lower urinary tract symptoms in real life practices.
European urology 2001;39 Suppl 3():1-5.
2001: Christopher Chapple
Alpha adrenoceptor antagonists in the year 2000: is there anything new?
Current opinion in urology 2001;11(1):9-16.
2001: Stephen Radley; Christopher Chapple; N P Bryan; David Ernest Clarke; D A Craig
Effect of methoxamine on maximum urethral pressure in women with genuine stress incontinence: a placebo-controlled, double-blind crossover study.
Neurourology and urodynamics 2001;20(1):43-52.
2000: Tomonori Yamanishi; Christopher Chapple; Kosaku Yasuda; Russell Chess-Williams
The role of M(2)-muscarinic receptors in mediating contraction of the pig urinary bladder in vitro.
British journal of pharmacology 2000;131(7):1482-8.
2000: Donna J Sellers; Russell Chess-Williams; Christopher Chapple
5-Hydroxytryptamine-induced potentiation of cholinergic responses to electrical field stimulation in pig detrusor muscle.
BJU international 2000;86(6):714-8.
2000: Derek J Rosario; Stephen Radley; Christopher Chapple
The pressure-flow plot in the evaluation of female incontinence.
BJU international 2000;86(4):564-5.
2000: N P Bryan; KJ Hastie; Christopher Chapple
Randomised prospective trial of contact laser prostatectomy (CLAP) versus visual laser coagulation of the prostate (VLAP) for the treatment of benign prostatic hyperplasia. 2-year follow-up.
European urology 2000;38(3):265-71.
2000: Christopher Chapple
Urethral injury.
BJU international 2000;86(3):318-26.
2000: Donna J Sellers; Tomonori Yamanishi; Christopher Chapple; C Couldwell; Kosaku Yasuda; Russell Chess-Williams
M3 muscarinic receptors but not M2 mediate contraction of the porcine detrusor muscle in vitro.
Journal of autonomic pharmacology 2000;20(3):171-6.
2000: J C Png; Christopher Chapple
Principles of ureteric reconstruction.
Current opinion in urology 2000;10(3):207-12.
2000: B Davis; M Goepel; S Bein; Russell Chess-Williams; Christopher Chapple; M C Michel
Lack of neuropeptide Y receptor detection in human bladder and prostate.
BJU international 2000;85(7):918-24.
2000: Christopher Chapple
Muscarinic receptor antagonists in the treatment of overactive bladder.
Urology 2000;55(5A Suppl):33-46; discussion 50.
2000: Linda Cardozo; Christopher Chapple; P Toozs-Hobson; M Grosse-Freese; M Bulitta; W Lehmacher; W Strösser; B Ballering-Brühl; M Schäfer
Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial.
BJU international 2000;85(6):659-64.
2000: Stephen Radley; Christopher Chapple; J A Lee
Transurethral implantation of silicone polymer for stress incontinence: evaluation of a porcine model and mechanism of action in vivo.
BJU international 2000;85(6):646-50.
2000: Christopher Chapple
Randomized controlled trials for benign prostatic obstruction: problems and pitfalls.
BJU international 2000;85 Suppl 1():54-7.
2000: M H Hawthorn; Christopher Chapple; M Cock; Russell Chess-Williams
Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro.
British journal of pharmacology 2000;129(3):416-9.
2000: Christopher Chapple
Randomised controlled trials versus real life practice in BPH. Introduction and concluding remarks.
European urology 2000;38 Suppl 1():1-6.
2000: Derek J Rosario; Christopher Chapple; P R Tophill; H H Woo
Urodynamic assessment of the bashful bladder.
The Journal of urology 2000;163(1):215-20.
1999: Karl-Erik Andersson; R Appell; L D Cardozo; Christopher Chapple; H P Drutz; A E Finkbeiner; F Haab; R Vela Navarrete
The pharmacological treatment of urinary incontinence.
BJU international 1999;84(9):923-47.
1999: Derek J Rosario; Stephen Radley; J R Goepel; Christopher Chapple
Renal infarction following spontaneous renal vein thrombosis in the puerperium.
British journal of obstetrics and gynaecology 1999;106(11):1223-4.
1999: H Christoph Klingler; A J Bretland; Sheilagh V Reid; Christopher Chapple; Colby L Eaton
Regulation of prostatic stromal cell growth and function by transforming growth factor beta (TGFbeta).
The Prostate 1999;41(2):110-20.
1999: Russell Chess-Williams; S W Martin; C Korstanje; Christopher Chapple
In vitro investigation of the bladder-vascular selectivity of levcromakalim and YM934 in human tissues.
BJU international 1999;83(9):1050-4.
1999: Christopher Chapple; D Png
Contemporary management of urethral trauma and the post-traumatic stricture.
Current opinion in urology 1999;9(3):253-60.
1999: Christopher Chapple
What's topical in functional reconstruction and trauma--with particular reference to urethroplasty.
Current opinion in urology 1999;9(3):223-6.
1999: TJ Williams; DR Blue; Donald V Daniels; B Davis; TR Elworthy; Joel R Gever; MS Kava; DJ Morgans; Fernando Padilla; S Tassa; RL Vimont; Christopher Chapple; R Chess-Williams; Richard M Eglen; DE Clarke; Anthony P D W Ford
In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
British journal of pharmacology 1999;127(1):252-8.
1999: Stephen Radley; Christopher Chapple; S W Martin; D Boaler
Point of Technique. A training model for transurethral injection therapy for stress incontinence.
BJU international 1999;83(6):711-3.
1999: Paul Abrams; G Larsson; Christopher Chapple; A J Wein
Factors involved in the success of antimuscarinic treatment.
BJU international 1999;83 Suppl 2():42-7.
1999: Derek J Rosario; S A MacDiarmid; Stephen Radley; Christopher Chapple
A comparison of ambulatory and conventional urodynamic studies in men with borderline outlet obstruction.
BJU international 1999;83(4):400-9.
1999: N P Bryan; L Byrne; KJ Hastie; John B Anderson; K T Moore; Christopher Chapple
A pilot study for a randomized controlled trial comparing the efficacy, safety and cost-effectiveness of surgical treatments of the prostate.
BJU international 1999;83(3):249-53.
1999: Jenny Donovan; Sara T Brookes; JJ de la Rosette; Tim J Peters; D Porru; A Kondo; Noshir Framroze Dabhoiwala; R Millard; R Bosch; Jørgen Nordling; A Matos-Ferreira; K Höfner; H Mostafid; S Walter; I Nissenkorn; C Frimodt Moller; M Mendes Silva; Christopher Chapple; Paul Abrams
The responsiveness of the ICSmale questionnaire to outcome: evidence from the ICS-'BPH' study.
BJU international 1999;83(3):243-8.
1999: Christopher Chapple; M M Issa; H Woo
Transurethral needle ablation (TUNA). A critical review of radiofrequency thermal therapy in the management of benign prostatic hyperplasia.
European urology 1999;35(2):119-28.
1999: Christopher Chapple
BHP Disease Management. Introduction and concluding remarks.
European urology 1999;36 Suppl 3():1-6.
1999: S Z Langer; R Kirby; M G Wyllie; David Ernest Clarke; K E Andersson; Christopher Chapple
Role of alpha1-adrenoceptors in the future treatment of urological diseases.
European urology 1999;36 Suppl 1():66-7.
1999: I Marshall; Richard P Burt; Christopher Chapple
Signal transduction pathways associated with alpha1-adrenoceptor subtypes in cells and tissues including human prostate.
European urology 1999;36 Suppl 1():42-7; discussion 65.
1999: Derek J Rosario; D J Smith; Stephen Radley; Christopher Chapple
Pharmacodynamics of anticholinergic agents measured by ambulatory urodynamic monitoring: a study of methodology.
Neurourology and urodynamics 1999;18(3):223-33; discussion 223-4.
1998: H C Klingler; H Woo; Derek J Rosario; P E Cutinha; J Anderson; Anthony Milford Ward; Christopher Chapple
The value of prostate specific antigen (PSA) density and free: total PSA ratio in selecting patients with a normal digital rectal examination and intermediate total PSA levels for further investigation.
British journal of urology 1998;82(3):393-7.
1998: Christopher Chapple
Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade.
British journal of urology 1998;81 Suppl 1():34-47; discussion 64-6.
1998: J Mountney; Christopher Chapple; A G Johnson
Giant hydronephrosis--a diagnostic dilemma.
Urologia internationalis 1998;61(2):121-3.
1998: Christopher Chapple; N P Bryan
Surgery for detrusor overactivity.
World journal of urology 1998;16(4):268-73.
1998: Christopher Chapple
Medical therapy and quality of life.
European urology 1998;34 Suppl 2():10-7; discussion 46.
1998: Christopher Chapple; R Chess-Williams
Latest developments in the field of neurotransmitters.
European urology 1998;34 Suppl 1():45-7.
1998: Richard P Burt; Christopher Chapple; I Marshall
Alpha1A-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC.
British journal of pharmacology 1998;123(2):317-25.
1997: Derek J Rosario; H Woo; K L Potts; P E Cutinha; KJ Hastie; Christopher Chapple
Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction.
British journal of urology 1997;80(4):579-86.
1997: S W Martin; Stephen Radley; Russell Chess-Williams; C Korstanje; Christopher Chapple
Relaxant effects of potassium-channel openers on normal and hyper-reflexic detrusor muscle.
British journal of urology 1997;80(3):405-13.
1997: R T Warwick; H Parkhouse; Christopher Chapple
Bulbar elongation anastomotic meatoplasty (BEAM) for subterminal and hypospadiac urethroplasty.
The Journal of urology 1997;158(3 Pt 2):1160-7.
1997: D J Smith; Christopher Chapple
A modified in vitro technique to evaluate human detrusor muscle.
British journal of urology 1997;79(2):285-7.
1997: Christopher Chapple; L Baert; P Thind; K Höfner; G S Khoe; A Spångberg
Tamsulosin 0.4 mg once daily: tolerability in older and younger patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (symptomatic BPH). The European Tamsulosin Study Group.
European urology 1997;32(4):462-70.
1997: A J Noble; Russell Chess-Williams; C Couldwell; K Furukawa; T Uchyiuma; C Korstanje; Christopher Chapple
The effects of tamsulosin, a high affinity antagonist at functional alpha 1A- and alpha 1D-adrenoceptor subtypes.
British journal of pharmacology 1997;120(2):231-8.
1996: Derek J Rosario; K L Potts; Christopher Chapple
Ambulatory urodynamic monitoring.
British journal of urology 1996;78(6):965-6.
1996: P E Cutinha; K L Potts; Derek J Rosario; KJ Hastie; K T Moore; Christopher Chapple
A prospective audit of the use of a prostate clinic.
British journal of urology 1996;78(5):733-6.
1996: Russell Chess-Williams; Christopher Chapple; F Verfurth; A J Noble; C J Couldwell; M C Michel
The effects of SB 216469, an antagonist which discriminates between the alpha 1A-adrenoceptor and the human prostatic alpha 1-adrenoceptor.
British journal of pharmacology 1996;119(6):1093-100.
1996: I Marshall; Richard P Burt; G M Green; M B Hussain; Christopher Chapple
Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053.
British journal of pharmacology 1996;119(2):407-15.
1996: Jenny Donovan; Paul Abrams; Tim J Peters; H E Kay; J Reynard; Christopher Chapple; J J De La Rosette; A Kondo
The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire.
British journal of urology 1996;77(4):554-62.
1996: D J Smith; R D Start; Christopher Chapple
Rheumatoid disease: an unusual cause of bladder outlet obstruction.
British journal of urology 1996;77(2):318.
1996: Richard P Burt; Christopher Chapple; I Marshall
The role of diacylglycerol and activation of protein kinase C in alpha 1A-adrenoceptor-mediated contraction to noradrenaline of rat isolated epididymal vas deferens.
British journal of pharmacology 1996;117(1):224-30.
1996: H H Woo; Derek J Rosario; Christopher Chapple
The treatment of vesicovaginal fistulae.
European urology 1996;29(1):1-9.
1996: H H Woo; Derek J Rosario; Christopher Chapple
A simple technique for the intra-operative placement of a suprapubic catheter.
British journal of urology 1996;77(1):153-4.
1996: H H Woo; Derek J Rosario; Christopher Chapple
Digitally-guided prostatic biopsies--the Sheffield biopsy guide.
British journal of urology 1996;77(1):152.
1996: Christopher Chapple; J J Wyndaele; J Nordling; F Boeminghaus; A F Ypma; Paul Abrams
Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group.
European urology 1996;29(2):155-67.
1996: Christopher Chapple
Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience.
European urology 1996;29(2):129-44.
1995: Richard P Burt; Christopher Chapple; I Marshall
The role of capacitative Ca2+ influx in the alpha 1B-adrenoceptor-mediated contraction to phenylephrine of the rat spleen.
British journal of pharmacology 1995;116(4):2327-33.
1995: K Furukawa; D J Rosario; D J Smith; Christopher Chapple; T Uchiyama; Russell Chess-Williams
Alpha 1A-adrenoceptor-mediated contractile responses of the human vas deferens.
British journal of pharmacology 1995;116(1):1605-10.
1995: I Marshall; Richard P Burt; Christopher Chapple
Noradrenaline contractions of human prostate mediated by alpha 1A-(alpha 1c-) adrenoceptor subtype.
British journal of pharmacology 1995;115(5):781-6.
1995: H H Woo; Derek J Rosario; Christopher Chapple
Stone formation on permanent suture material used previously in colposuspension.
British journal of urology 1995;76(1):139-40.
1995: Christopher Chapple
Alpha-adrenergic blocking drugs in bladder outflow obstruction: what potential has alpha 1-adrenoceptor selectivity?
British journal of urology 1995;76 Suppl 1():47-55.
1995: Richard P Burt; Christopher Chapple; I Marshall
Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
British journal of pharmacology 1995;115(3):467-75.
1995: R S Kirby; G Chisholm; Christopher Chapple; C Hudd; M Swallow; D Shore
Shared care between general practitioners and urologists in the management of benign prostatic hyperplasia: a survey of attitudes among clinicians.
Journal of the Royal Society of Medicine 1995;88(5):284P-288P.
1995: Derek J Rosario; H H Woo; H Parkhouse; Christopher Chapple
Effects of intravenous thyrotropin-releasing hormone on urethral closure pressure in females with voiding dysfunction.
European urology 1995;28(1):64-7.
1995: S MacDiarmid; Derek J Rosario; Christopher Chapple
The importance of accurate assessment and conservative management of the open bladder neck in patients with post-pelvic fracture membranous urethral distraction defects.
British journal of urology 1995;75(1):65-7.
1994: Christopher Chapple; Richard P Burt; P O Andersson; P Greengrass; M Wyllie; I Marshall
Alpha 1-adrenoceptor subtypes in the human prostate.
British journal of urology 1994;74(5):585-9.
1994: Christopher Chapple; P Carter; T J Christmas; R S Kirby; J Bryan; E J Milroy; Paul Abrams
A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction.
British journal of urology 1994;74(1):50-6.
1994: D J Smith; Freddie C Hamdy; Christopher Chapple
An uncommon complication of circumcision.
British journal of urology 1994;73(4):459-60.
1994: D J Smith; H J Evans; J Newman; Christopher Chapple
Ectopic human chorionic gonadotrophin (HCG) production: is the detection by serum analysis of HCG of clinical relevance in transitional cell carcinoma of the bladder?
British journal of urology 1994;73(4):409-12.
1994: D J Smith; S K Survarna; Christopher Chapple
Pelvic malakoplakia--an unusual bladder tumour.
British journal of urology 1994;73(3):322-3.
1994: Christopher Chapple; D Smith
The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia.
British journal of urology 1994;73(2):117-23.
1994: D J Smith; F C Handy; J W Evans; M Falzon; Christopher Chapple
Paget's disease of the glans penis: an unusual urological malignancy.
European urology 1994;25(4):316-9.
1994: J G Noble; A M Parikh; Christopher Chapple; P H Worth; E J Milroy
Renal adenocarcinoma in young adults.
Urologia internationalis 1994;53(1):40-3.
1993: D J Smith; C M Milroy; Christopher Chapple
An unusual renal mass: ?Wegener's granulomatosis.
British journal of urology 1993;72(6):980-1.
1993: E Milroy; Christopher Chapple
The UroLume stent in the management of benign prostatic hyperplasia.
The Journal of urology 1993;150(5 Pt 2):1630-5.
1993: Christopher Chapple; J G Noble; E J Milroy
Comparative study of selective alpha 1-adrenoceptor blockade versus surgery in the treatment of prostatic obstruction.
British journal of urology 1993;72(5 Pt 2):822-5.
1993: J G Noble; Christopher Chapple
Formation of a urethral calculus around an unusual foreign body.
British journal of urology 1993;72(2):248-9.
1993: A M Parikh; Christopher Chapple
Suprapubic catheter--an unusual cause of acute retention.
British journal of urology 1993;71(4):494-5.
1993: Robert Janknegt; Christopher Chapple
Efficacy and safety of the alpha-1 blocker doxazosin in the treatment of benign prostatic hyperplasia. Analysis of 5 studies. Doxazosin Study Groups.
European urology 1993;24(3):319-26.
1992: Christopher Chapple; Pam Milner; H E Moss; G Burnstock
Loss of sensory neuropeptides in the obstructed human bladder.
British journal of urology 1992;70(4):373-81.
1992: Christopher Chapple; M Stott; P H Abrams; T J Christmas; E J Milroy
A 12-week placebo-controlled double-blind study of prazosin in the treatment of prostatic obstruction due to benign prostatic hyperplasia.
British journal of urology 1992;70(3):285-94.
1992: Christopher Chapple; S W Coppinger; R T Turner-Warwick
Is urethral pressure profilometry useful in the preoperative assessment of benign prostatic hyperplasia?
British journal of urology 1992;70(3):280-4.
1992: A Parikh; Christopher Chapple; S J Hampson
Suprapubic catheterisation and bowel injury.
British journal of urology 1992;70(2):212-3.
1992: Christopher Chapple
Medical treatment for benign prostatic hyperplasia.
BMJ (Clinical research ed.) 1992;304(6836):1198-9.
1992: J G Noble; T J Christmas; Christopher Chapple; D Rickards
Inguinal bladder hernia associated with vesico-ureteric reflux.
Postgraduate medical journal 1992;68(798):299-300.
1992: J W Evans; M Singer; Christopher Chapple; N Macartney; J M Walker; E J Milroy
Haemodynamic evidence for cardiac stress during transurethral prostatectomy.
BMJ (Clinical research ed.) 1992;304(6828):666-71.
1992: J S Gelister; M Falzon; R Crawford; Christopher Chapple; W F Hendry
Urinary tract metastasis from renal carcinoma.
British journal of urology 1992;69(3):250-2.
1991: Christopher Chapple; R Crowe; S A Gilpin; J Gosling; G Burnstock
The innervation of the human prostate gland--the changes associated with benign enlargement.
The Journal of urology 1991;146(6):1637-44.
1991: Christopher Chapple; S J Hampson; R T Turner-Warwick; P H Worth
Subtrigonal phenol injection. How safe and effective is it?
British journal of urology 1991;68(5):483-6.
1991: Christopher Chapple
Alfuzosin for benign prostatic hypertrophy.
Lancet 1991;338(8760):182.
1991: I Eardley; K Nagendran; B Lecky; Christopher Chapple; R S Kirby; C J Fowler
Neurophysiology of the striated urethral sphincter in multiple sclerosis.
British journal of urology 1991;68(1):81-8.
1991: R Crowe; Christopher Chapple; G Burnstock
The human prostate gland: a histochemical and immunohistochemical study of neuropeptides, serotonin, dopamine beta-hydroxylase and acetylcholinesterase in autonomic nerves and ganglia.
British journal of urology 1991;68(1):53-61.
1991: D J Ralph; Christopher Chapple; J W Evans
Seeding of transitional cell carcinoma within the vagina.
British journal of urology 1991;67(6):660-1.
1991: J W Evans; M Singer; Christopher Chapple; N Macartney; S W Coppinger; E J Milroy
Haemodynamic evidence for per-operative cardiac stress during transurethral prostatectomy. Preliminary communication.
British journal of urology 1991;67(4):376-80.
1991: R Crowe; H E Moss; Christopher Chapple; J K Light; G Burnstock
Patients with lower motor spinal cord lesion: a decrease of vasoactive intestinal polypeptide, calcitonin gene-related peptide and substance P, but not neuropeptide Y and somatostatin-immunoreactive nerves in the detrusor muscle of the bladder.
The Journal of urology 1991;145(3):600-4.
1991: G A Fowlis; S J Hampson; Christopher Chapple; M Falzon; P H Worth
Extrarenal adult Wilms tumour: presentation, diagnosis and management.
European urology 1991;20(4):336-8.
1990: Christopher Chapple; H Parkhouse; C Gardener; E J Milroy
Double-blind, placebo-controlled, cross-over study of flavoxate in the treatment of idiopathic detrusor instability.
British journal of urology 1990;66(5):491-4.
1990: Christopher Chapple; E J Milroy; D Rickards
Permanently implanted urethral stent for prostatic obstruction in the unfit patient. Preliminary report.
British journal of urology 1990;66(1):58-65.
1990: P J Dixon; T J Christmas; Christopher Chapple
Stress incontinence due to pelvic floor muscle involvement in limb-girdle muscular dystrophy.
British journal of urology 1990;65(6):653-4.
1990: J W Evans; Christopher Chapple; D J Ralph; E J Milroy
Bladder calculus formation as a complication of the Stamey procedure.
British journal of urology 1990;65(6):580-2.
1990: A E Boothroyd; P J Dixon; T J Christmas; Christopher Chapple; D Rickards
The ultrasound cystodynamogram--a new radiological technique.
The British journal of radiology 1990;63(749):331-2.
1990: Christopher Chapple; T J Christmas; R T Turner-Warwick
Vesicoureteric reflux in the adult male.
British journal of urology 1990;65(2):144-7.
1990: Christopher Chapple; J Malone-Lee
A new comprehensive microcomputer software programme for the urodynamics clinic.
European urology 1990;18(1):33-6.
1990: Christopher Chapple; S C Blease; D Rickards
What is the clinical significance of urethroprostatic reflux as a radiological finding during videocystourethrography in neurologically normal patients?
European urology 1990;17(4):296-8.
1990: T J Christmas; J Rode; Christopher Chapple; E J Milroy; R T Turner-Warwick
Nerve fibre proliferation in interstitial cystitis.
Virchows Archiv. A, Pathological anatomy and histopathology 1990;416(5):447-51.
1990: Christopher Chapple; T J Christmas; E J Milroy
A twelve-week placebo-controlled study of prazosin in the treatment of prostatic obstruction.
Urologia internationalis 1990;45 Suppl 1():47-55.
1989: Charles Hoyle; Christopher Chapple; G Burnstock
Isolated human bladder: evidence for an adenine dinucleotide acting on P2X-purinoceptors and for purinergic transmission.
European journal of pharmacology 1989;174(1):115-8.
1989: J F Buckley; Christopher Chapple; T McNicholas
Continuous infusion of phenylephrine in the treatment of papaverine-induced priapism.
British journal of urology 1989;64(6):654-5.
1989: J S Gelister; J D Sanderson; Christopher Chapple; Jeffrey L H O'Riordan; A G Cowie; E J Milroy
Management of hyperparathyroidism in pregnancy.
The British journal of surgery 1989;76(11):1207-8.
1989: Christopher Chapple; C W Helm; S Blease; E J Milroy; D Rickards; J L Osborne
Asymptomatic bladder neck incompetence in nulliparous females.
British journal of urology 1989;64(4):357-9.
1989: Christopher Chapple; E G Milroy
Use of stents for treating obstruction of urinary outflow.
BMJ (Clinical research ed.) 1989;299(6702):795.
1989: S James; Christopher Chapple; M I Phillips; P M Greengrass; M J Davey; R T Turner-Warwick; E J Milroy; G Burnstock
Autoradiographic analysis of alpha-adrenoceptors and muscarinic cholinergic receptors in the hyperplastic human prostate.
The Journal of urology 1989;142(2 Pt 1):438-44.
1989: Christopher Chapple; J Gelister; R A Miller
Minimally invasive surgery for the retrieval of complex fractured double J stents.
The British journal of surgery 1989;76(7):680.
1989: E J Milroy; Christopher Chapple; A Eldin; H Wallsten
A new treatment for urethral strictures: a permanently implanted urethral stent.
The Journal of urology 1989;141(5):1120-2.
1989: T J Christmas; Christopher Chapple; D Rickards; E J Milroy; R T Turner-Warwick
Contemporary flow meters: an assessment of their accuracy and reliability.
British journal of urology 1989;63(5):460-1.
1989: Christopher Chapple; M L Aubry; S James; P M Greengrass; G Burnstock; R T Turner-Warwick; E J Milroy; M J Davey
Characterisation of human prostatic adrenoceptors using pharmacology receptor binding and localisation.
British journal of urology 1989;63(5):487-96.
1989: E J Milroy; Christopher Chapple; A Eldin; H Wallsten
A new stent for the treatment of urethral strictures. Preliminary report.
British journal of urology 1989;63(4):392-6.
1989: T J Christmas; Christopher Chapple; S D Payne; E J Milroy; R T Warwick
Bonney's blue cystitis: a warning.
British journal of urology 1989;63(3):281-3.
1989: J G Noble; Christopher Chapple; T J Christmas; R Phillips; D Rickards
Renal angiomyolipoma: a comparison of 5 cases diagnosed by CT scan.
Journal of the Royal Society of Medicine 1989;82(1):25-7.
1989: J G Noble; T J Christmas; Christopher Chapple; D Katz; E J Milroy
The black thyroid: an unusual finding during neck exploration.
Postgraduate medical journal 1989;65(759):34-5.
1988: T J Christmas; P A Kempster; Christopher Chapple; J P Frankel; Andrew J Lees; G M Stern; E J Milroy
Role of subcutaneous apomorphine in parkinsonian voiding dysfunction.
Lancet 1988;2(8626-8627):1451-3.
1988: C J Fowler; T J Christmas; Christopher Chapple; H F Parkhouse; R S Kirby; H S Jacobs
Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome?
BMJ (Clinical research ed.) 1988;297(6661):1436-8.
1988: E Milroy; Christopher Chapple
The aetiology and treatment of benign prostatic obstruction.
The Practitioner 1988;232(1456 ( Pt 2)):1141-5.
1988: Christopher Chapple; S Muller; J Newman
Gastric adenocarcinoma associated with adenomyoma of the stomach.
Postgraduate medical journal 1988;64(756):801-3.
1988: T J Christmas; Christopher Chapple; J G Noble; E J Milroy; A G Cowie
Hyperparathyroidism after neck irradiation.
The British journal of surgery 1988;75(9):873-4.
1988: T J Christmas; Christopher Chapple; E J Milroy; R T Warwick
Bonney's blue.
Lancet 1988;2(8608):459-60.
1988: E J Milroy; Christopher Chapple; J E Cooper; A Eldin; H Wallsten; A M Seddon; P M Rowles
A new treatment for urethral strictures.
Lancet 1988;1(8600):1424-7.
1988: G N Antonakopoulos; Christopher Chapple; J Newman; J Crocker; D C Tudway; J M O'Brien; J Considine
Xanthogranulomatous pyelonephritis. A reappraisal and immunohistochemical study.
Archives of pathology & laboratory medicine 1988;112(3):275-81.
1987: V M Shah; J Newman; J Crocker; G N Antonakopoulos; Christopher Chapple; M J Collard
Production of beta-human chorionic gonadotropin by prostatic adenocarcinoma and transitional cell carcinoma of the upper urinary tract.
British journal of experimental pathology 1987;68(6):871-8.
1987: Christopher Chapple; J Newman; J M O'Brien; J Considine
Adenocarcinoma in the free wall of a simple renal cyst.
Journal of the Royal College of Surgeons of Edinburgh 1987;32(5):320-1.
1987: R S Kirby; S W Coppinger; M O Corcoran; Christopher Chapple; M Flannigan; E J Milroy
Prazosin in the treatment of prostatic obstruction. A placebo-controlled study.
British journal of urology 1987;60(2):136-42.
1987: Christopher Chapple; M X Gannon; V M Shah; J Newman
Spontaneous regression of pulmonary metastases from renal adenocarcinoma before nephrectomy.
The British journal of surgery 1987;74(1):69-70.
1987: Christopher Chapple; J Newman; J M O'Brien; J Considine
Analgesic nephropathy complicated by transitional cell carcinoma of the renal pelvis.
British journal of urology 1987;59(1):89.
1986: Christopher Chapple; A N Fraser
Pasteurella multocida wound infections--a commonly unrecognized problem in the casualty department.
Injury 1986;17(6):410-1.
1986: Christopher Chapple; I M Chesner; J Newman
Multiple myeloma presenting as intractable gastric retention in a patient with a previous gastroenterostomy.
The British journal of surgery 1986;73(11):930.
1986: Christopher Chapple; V M Shah; J Newman
Intraluminal mucus cast complicating carcinoma of the colon.
Postgraduate medical journal 1986;62(733):1061-2.
1986: V M Shah; J Newman; J Crocker; Christopher Chapple; M J Collard; J M O'Brien; J Considine
Ectopic beta-human chorionic gonadotropin production by bladder urothelial neoplasia.
Archives of pathology & laboratory medicine 1986;110(2):107-11.
1985: Christopher Chapple; J Newman; J M O'Brien; J Considine
Transitional cell carcinoma of the upper renal tract in rubber workers.
Postgraduate medical journal 1985;61(719):837-8.
1985: R S Kirby; Christopher Chapple; S P Ward; C Williams
Is the scrotal testis normal in unilateral cryptorchidism?
British journal of urology 1985;57(2):187-9.
1984: Christopher Chapple; K M Porter
An unusual use for the arthroscope.
Injury 1984;15(5):351-2.
1980: Christopher Chapple; B A Wood
Venous drainage of the hind limb in the monkey (macaca fascicularis).
Journal of anatomy 1980;131(Pt 1):157-71.